GILEAD SCIENCES INC (GIS.DE) Fundamental Analysis & Valuation

FRA:GIS • US3755581036

126.3 EUR
-1.76 (-1.37%)
Last: Mar 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This GIS.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Overall GIS gets a fundamental rating of 7 out of 10. We evaluated GIS against 75 industry peers in the Biotechnology industry. GIS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. GIS is not valued too expensively and it also shows a decent growth rate. These ratings could make GIS a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. GIS.DE Profitability Analysis

1.1 Basic Checks

  • In the past year GIS was profitable.
  • In the past year GIS had a positive cash flow from operations.
  • Each year in the past 5 years GIS has been profitable.
  • Each year in the past 5 years GIS had a positive operating cash flow.
GIS.DE Yearly Net Income VS EBIT VS OCF VS FCFGIS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

1.2 Ratios

  • With an excellent Return On Assets value of 14.42%, GIS belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.
  • With an excellent Return On Equity value of 37.49%, GIS belongs to the best of the industry, outperforming 96.00% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 19.49%, GIS belongs to the best of the industry, outperforming 97.33% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for GIS is significantly above the industry average of 12.19%.
  • The last Return On Invested Capital (19.49%) for GIS is above the 3 year average (17.55%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROIC 19.49%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
GIS.DE Yearly ROA, ROE, ROICGIS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • GIS's Profit Margin of 28.90% is amongst the best of the industry. GIS outperforms 85.33% of its industry peers.
  • In the last couple of years the Profit Margin of GIS has grown nicely.
  • The Operating Margin of GIS (39.98%) is better than 93.33% of its industry peers.
  • GIS's Operating Margin has been stable in the last couple of years.
  • GIS has a better Gross Margin (78.83%) than 68.00% of its industry peers.
  • In the last couple of years the Gross Margin of GIS has remained more or less at the same level.
Industry RankSector Rank
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
GIS.DE Yearly Profit, Operating, Gross MarginsGIS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. GIS.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), GIS is creating value.
  • Compared to 1 year ago, GIS has less shares outstanding
  • GIS has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, GIS has an improved debt to assets ratio.
GIS.DE Yearly Shares OutstandingGIS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
GIS.DE Yearly Total Debt VS Total AssetsGIS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 4.62 indicates that GIS is not in any danger for bankruptcy at the moment.
  • GIS's Altman-Z score of 4.62 is fine compared to the rest of the industry. GIS outperforms 76.00% of its industry peers.
  • The Debt to FCF ratio of GIS is 2.64, which is a good value as it means it would take GIS, 2.64 years of fcf income to pay off all of its debts.
  • GIS has a Debt to FCF ratio of 2.64. This is amongst the best in the industry. GIS outperforms 85.33% of its industry peers.
  • GIS has a Debt/Equity ratio of 0.97. This is a neutral value indicating GIS is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.97, GIS perfoms like the industry average, outperforming 44.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Altman-Z 4.62
ROIC/WACC2.41
WACC8.07%
GIS.DE Yearly LT Debt VS Equity VS FCFGIS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • GIS has a Current Ratio of 1.55. This is a normal value and indicates that GIS is financially healthy and should not expect problems in meeting its short term obligations.
  • GIS's Current ratio of 1.55 is in line compared to the rest of the industry. GIS outperforms 42.67% of its industry peers.
  • A Quick Ratio of 1.40 indicates that GIS should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.40, GIS perfoms like the industry average, outperforming 45.33% of the companies in the same industry.
  • The current and quick ratio evaluation for GIS is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.4
GIS.DE Yearly Current Assets VS Current LiabilitesGIS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. GIS.DE Growth Analysis

3.1 Past

  • GIS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.79%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 2.83% on average over the past years.
  • The Revenue has been growing slightly by 2.40% in the past year.
  • The Revenue has been growing slightly by 3.58% on average over the past years.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%

3.2 Future

  • GIS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.47% yearly.
  • Based on estimates for the next years, GIS will show a small growth in Revenue. The Revenue will grow by 4.32% on average per year.
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue Next Year3.45%
Revenue Next 2Y4.63%
Revenue Next 3Y4.54%
Revenue Next 5Y4.32%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GIS.DE Yearly Revenue VS EstimatesGIS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
GIS.DE Yearly EPS VS EstimatesGIS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. GIS.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.99, GIS is valued on the expensive side.
  • Based on the Price/Earnings ratio, GIS is valued cheaply inside the industry as 85.33% of the companies are valued more expensively.
  • GIS is valuated rather cheaply when we compare the Price/Earnings ratio to 26.83, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 16.43, GIS is valued correctly.
  • Based on the Price/Forward Earnings ratio, GIS is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 24.95. GIS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.99
Fwd PE 16.43
GIS.DE Price Earnings VS Forward Price EarningsGIS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 84.00% of the companies in the same industry are more expensive than GIS, based on the Enterprise Value to EBITDA ratio.
  • GIS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GIS is cheaper than 90.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.23
EV/EBITDA 13.49
GIS.DE Per share dataGIS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GIS does not grow enough to justify the current Price/Earnings ratio.
  • GIS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.91
PEG (5Y)6.37
EPS Next 2Y8.64%
EPS Next 3Y8.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. GIS.DE Dividend Analysis

5.1 Amount

  • GIS has a Yearly Dividend Yield of 2.28%.
  • GIS's Dividend Yield is rather good when compared to the industry average which is at 0.62. GIS pays more dividend than 94.67% of the companies in the same industry.
  • GIS's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.28%

5.2 History

  • The dividend of GIS has a limited annual growth rate of 3.30%.
Dividend Growth(5Y)3.3%
Div Incr Years6
Div Non Decr Years6
GIS.DE Yearly Dividends per shareGIS.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 47.04% of the earnings are spent on dividend by GIS. This is a bit on the high side, but may be sustainable.
  • The dividend of GIS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP47.04%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
GIS.DE Yearly Income VS Free CF VS DividendGIS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
GIS.DE Dividend Payout.GIS.DE Dividend Payout, showing the Payout Ratio.GIS.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GIS.DE Fundamentals: All Metrics, Ratios and Statistics

GILEAD SCIENCES INC

FRA:GIS (3/3/2026, 7:00:00 PM)

126.3

-1.76 (-1.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)04-22
Inst Owners91.58%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap156.70B
Revenue(TTM)29.44B
Net Income(TTM)8.51B
Analysts81.62
Price Target134.83 (6.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.28%
Yearly Dividend2.73
Dividend Growth(5Y)3.3%
DP47.04%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.2%
Min EPS beat(2)0.73%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)3.61%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)7
Avg EPS beat(8)10.97%
EPS beat(12)8
Avg EPS beat(12)7.27%
EPS beat(16)12
Avg EPS beat(16)9.04%
Revenue beat(2)2
Avg Revenue beat(2)1.64%
Min Revenue beat(2)0.98%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)2.29%
Revenue beat(8)6
Avg Revenue beat(8)1.67%
Revenue beat(12)8
Avg Revenue beat(12)0.99%
Revenue beat(16)12
Avg Revenue beat(16)2.6%
PT rev (1m)16.75%
PT rev (3m)17.89%
EPS NQ rev (1m)-7.95%
EPS NQ rev (3m)-7.15%
EPS NY rev (1m)-0.14%
EPS NY rev (3m)1.15%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-1.32%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 17.99
Fwd PE 16.43
P/S 6.18
P/FCF 19.23
P/OCF 18.15
P/B 8.01
P/tB N/A
EV/EBITDA 13.49
EPS(TTM)7.02
EY5.56%
EPS(NY)7.69
Fwd EY6.08%
FCF(TTM)6.57
FCFY5.2%
OCF(TTM)6.96
OCFY5.51%
SpS20.45
BVpS15.77
TBVpS-1.8
PEG (NY)1.91
PEG (5Y)6.37
Graham Number49.9
Profitability
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROCE 24.94%
ROIC 19.49%
ROICexc 25.18%
ROICexgc 81.81%
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
FCFM 32.11%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
ROICexc(3y)21.91%
ROICexc(5y)20.22%
ROICexgc(3y)88.7%
ROICexgc(5y)94.18%
ROCE(3y)22.46%
ROCE(5y)21.44%
ROICexgc growth 3Y-8.45%
ROICexgc growth 5Y-2.47%
ROICexc growth 3Y8.85%
ROICexc growth 5Y10%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
F-Score8
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Debt/EBITDA 1.52
Cap/Depr 20.4%
Cap/Sales 1.91%
Interest Coverage 11.36
Cash Conversion 68.94%
Profit Quality 111.11%
Current Ratio 1.55
Quick Ratio 1.4
Altman-Z 4.62
F-Score8
WACC8.07%
ROIC/WACC2.41
Cap/Depr(3y)20.34%
Cap/Depr(5y)24.78%
Cap/Sales(3y)1.96%
Cap/Sales(5y)2.14%
Profit Quality(3y)796.33%
Profit Quality(5y)548.85%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%
Revenue Next Year3.45%
Revenue Next 2Y4.63%
Revenue Next 3Y4.54%
Revenue Next 5Y4.32%
EBIT growth 1Y8.73%
EBIT growth 3Y1.14%
EBIT growth 5Y3.47%
EBIT Next Year18.57%
EBIT Next 3Y11.36%
EBIT Next 5Y8.77%
FCF growth 1Y-8.25%
FCF growth 3Y4.25%
FCF growth 5Y4.69%
OCF growth 1Y-7.48%
OCF growth 3Y3.36%
OCF growth 5Y4.17%

GILEAD SCIENCES INC / GIS.DE FAQ

What is the fundamental rating for GIS stock?

ChartMill assigns a fundamental rating of 7 / 10 to GIS.DE.


What is the valuation status of GILEAD SCIENCES INC (GIS.DE) stock?

ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (GIS.DE). This can be considered as Fairly Valued.


How profitable is GILEAD SCIENCES INC (GIS.DE) stock?

GILEAD SCIENCES INC (GIS.DE) has a profitability rating of 9 / 10.


What is the financial health of GILEAD SCIENCES INC (GIS.DE) stock?

The financial health rating of GILEAD SCIENCES INC (GIS.DE) is 8 / 10.


Can you provide the expected EPS growth for GIS stock?

The Earnings per Share (EPS) of GILEAD SCIENCES INC (GIS.DE) is expected to grow by 9.44% in the next year.